BIOCON:NSE
Biocon
358,65 ₹
arrow_downward
-0,99%(-3,60) 1d
30 d’abr., 15:30:01 GMT+5:30 · INR
search
Tots els símbols
1d
5d
1m
6m
YTD
1a
5a
Màx.
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a BIOCON...
Obre
360,50 ₹
Alt
361,65 ₹
Baix
354,25 ₹
Capitalització borsària
580,84 kM
Volum mitjà
3,39 M
Volum
2,00 M
Dividend
0,14 %
Dividend trimestral
0,13 ₹
Data de l'exdividend
4 de jul. 2025
Ràtio preu-benefici
73,95
Alt 52 setmanes
424,95 ₹
Baix 52 setmanes
317,00 ₹
BPA
4,85 ₹
Accions en circulació
600,00 M
Nombre d'empleats
16 k
Notícies
De fonts en tot el web
Perfil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. The company was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Sobre Biocon
Conseller delegatSiddharth Mittal
Empleats16,4 k
Fundació29 de nov. 1978
Seu principalBangalore, Estat de Karnataka, Índia
Sector-
Lloc webbiocon.com
El contingut d'IA pot incloure errors. Més informació